Skip to main content

Grafa News and Videos — Page 1488

Latest

Grafa

Aligos Therapeutics secures $445M licensing deal with Amoytop for HBV candidate in China

Aligos Therapeutics (NASDAQ:ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for viral and liver diseases, announced on April 16, 2026, that it has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech.

Read more: Aligos Therapeutics secures $445M licensing deal with Amoytop for HBV candidate in China

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift